JBM (Healthcare) Ltd. 2161

HKEX · Hong Kong SAR China · Health Technology

HKD 1.62-0.01 (-0.61%)

Market closed· Oct 2, 2026, 7:35 AM UTC· HKD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

JBM (Healthcare) Ltd. 2161

HKEX · Hong Kong SAR China · Health Technology

HKD 1.62-0.01 (-0.61%)

Market closed· Oct 2, 2026, 7:35 AM UTC· HKD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-38.87% · 6MFull-screen chart

Open HKD 1.62High HKD 1.63Low HKD 1.60Close HKD 1.62Volume 106.00K

Oct 2, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: HKD 1.63
Day range: HKD 1.60 – HKD 1.63
52-week range: HKD 1.60 – HKD 3.11
Volume: 106.00K
Market cap: HKD 1.34B
P/E (TTM): 6.6
Dividend yield (annualized): 10.49%
Next earnings date: 2026-11-17
Avg. volume (1Y): 342.91K

Performance

1 week

-0.92%

1 month

-10.82%

3 months

-14.00%

6 months

-38.93%

Year to date

-36.39%

1 year

-41.73%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Generic
Country: Hong Kong SAR China
Exchange: HKEX
Shares outstanding: 817.30M
Employees: 404
ISIN: KYG1090B1077
Beta: 0.36

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceNov 18, 2025

Asian Penny Stocks With Market Caps Under US$400M

As global markets navigate a landscape marked by mixed performances and cautious economic outlooks, investors are increasingly exploring diverse opportunities. Penny stocks, often seen as remnants of past market eras, continue to offer intriguing prospects due to their affordability and potential for growth. By focusing on companies with strong financial foundations, these investments can reveal hidden value and unexpected returns in the ever-evolving Asian market.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.